噻奈普汀钠; 7-[(3-氯-6,11-二氢-5,5-二氧-6-甲基二苯并-[c,f][1,2]噻唑平-11-基)氨基]庚酸钠盐; 噻奈普汀钠水合物; 7-[[3-氯-6,11-二氢-6-甲基二苯并[c,f][1,2]硫氮杂卓-11-基]氨基]庚酸S,S-二氧化物钠盐; 噻奈普丁钠盐; 噻萘普汀钠
UNII:7LI031265R; UNII:YG0E19592I; Tianeptine Sodium Salt; EINECS 250-059-3; Heptanoic acid, 7-[(3-chloro-6,11-dihydro-6-methyl-5,5-dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]-, sodium salt (1:1); Sodium 7-[(3-chloro-6-methyl-5,5-dioxido-6,11-dihydrodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate; MFCD00879851; UNII:ROJ48D5596; Tianeptine sodium salt,7-[(3-Chloro-6,11-dihydro-6-methyl-5,5-dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoicacidsodiumsalt; Tianeptine Sodium; Tianeptine Sodium Salt Hydrate; Tianeptine (sodium salt); Tianeptine sodium salt; Sodium 7-[(3-chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoate S,S-dioxide; [7-[(3-Chloro-6,11-dihydro-6-methyldibenzo[c,f][1,2]thiazepine 5,5-dioxide)-11-ylamino]heptanoic acid]sodium salt
Desiccate at RT
1.疏水参数计算参考值(XlogP):无 2.氢键供体数量:1 3.氢键受体数量:6 4.可旋转化学键数量:8 5.互变异构体数量:无 6.拓扑分子极性表面积97.9 7.重原子数量:30 8.表面电荷:0 9.复杂度:660 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:1 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:2
PDF: 30123-17-2_ch
PDF: 30123-17-2_en